PNDRI Welcomes Two New Trustees
Former King County Executive and Deputy Secretary of the U.S. Department of Housing and Urban Development, Ron Sims, joins PNDRI board
Seattle– March 28, 2014 - Pacific Northwest Diabetes Research Institute (PNDRI) announced today the addition of two new Trustees to its Board. Former King County Executive and Deputy Secretary of the United States Department of Housing and Urban Development, Ron Sims, joined the PNDRI Board along with Neil McDonnell, Senior Vice President and Therapeutic Area Leader for Cardiovascular and Metabolic Diseases at Takeda Pharmaceuticals International.
“We are pleased to welcome these exceptional individuals to PNDRI’s Board of Trustees,” said John Wecker, President and CEO. “Ron and Neil each bring a unique and valuable skill set that strengthens our Board and enhances our ability to deliver on our mission.”
Ron Sims was appointed by President Obama to Deputy Secretary of the U.S. Department of Housing and Urban Development and served from 2009 to 2011. Prior to his HUD appointment, he served as King County Executive for 12 years. Sims was named Leader of the Year by American City and County Magazine in July, 2008 and was recognized as one of Governing Magazine's Government Officials of the Year in 2007. Along with his strong community and political ties, Sims brings a personal interest in diabetes to his new position as trustee. “Diabetes has had a dramatic impact on my family and the lives of millions of others,” says Mr. Sims. “I believe the effective treatment of diabetes will be authored by the Pacific Northwest Diabetes Research Institute.”
As Senior Vice President at Takeda, Neil McDonnell is responsible for setting and overseeing Takeda’s strategy in cardiovascular and metabolic disease. Previously, he was the Deputy Director of Strategy for the Global Health Program at the Bill & Melinda Gates Foundation. He is a graduate of the University of Washington where he received both his Pharm.D and B.S. Pharm.
“Making progress against diabetes requires vision, drive and commitment,” said Wecker. “Looking forward, the Board will play a critical role in shaping and driving a path that leads to improving the lives of those at risk and living with diabetes.